Vasospasm: my first 25 years-what worked? what didn't? what next? (Q39103863)

9 September 2017

title

Vasospasm: my first 25 years-what worked? what didn't? what next? (English)

1 reference

9 September 2017

R Loch Macdonald

1

1 reference

9 September 2017

publication date

1 January 2015

1 reference

Acta Neurochirurgica. Supplementum

9 September 2017

published in

1 reference

9 September 2017

volume

120

1 reference

9 September 2017

page(s)

1-10

1 reference

Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

A concerted appeal for international cooperation in preclinical stroke research

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Calcium antagonists for aneurysmal subarachnoid haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Antiplatelet therapy for aneurysmal subarachnoid haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Early brain injury, an evolving frontier in subarachnoid hemorrhage research

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Dissecting the genomic complexity underlying medulloblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Resuscitation and critical care of poor-grade subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Locally-administered Intrathecal Thrombolytics Following Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

RIGOR guidelines: escalating STAIR and STEPS for effective translational research

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Delayed neurological deterioration after subarachnoid haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Subarachnoid Hemorrhage International Trialists data repository (SAHIT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Acute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: incidence, predictors, and outcomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the International Subarachnoid Aneurysm Trial (ISAT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

The importance of early brain injury after subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Counterpoint: evidence-based medicine lacks a sound scientific base

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

The relationship between timing of surgery and operative complications in aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Can animal models of disease reliably inform human studies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Time course of vasospasm in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

Genome-wide association study of intracranial aneurysm identifies three new risk loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-04981-6_1

10.1007/978-3-319-04981-6_1

31 March 2020

Identifiers

DOI

1 reference

9 September 2017

1 reference